LGALS3 and heart failure: A long-term follow-up study showed a significant increase in the rate of new-set heart failure with increased galectin-3 concentrations (21), Another spanning 10 years study also found that dynamically elevated galectin-3 level was more closely associated with new-set heart failure and mortality (52).